§09 · Masthead
About PT-141 Safe
An independent editorial datasheet on PT-141 (bremelanotide) — built to draw the regulatory line cleanly and source every claim.
What this site is
PT-141 Safe is an independent editorial project that publishes summaries of the peer-reviewed research and regulatory record on PT-141 (bremelanotide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site exists because the public record on this compound is unusually easy to misread. One name covers two very different things — an FDA-approved prescription drug with a narrow, specific indication, and a "research chemical" sold outside that approval. Our job is to draw that line cleanly and put a source on every fact.
The 'safe' in the name
The word "safe" in our name is editorial framing, not a safety claim about the compound. It names the posture we take toward the literature: the posture of a careful reader doing due diligence, asking whether a claim is approved or off-label, whether it is well-established or contested, and whether the thing being discussed is the reviewed drug or the unregulated research-chemical form.
We make no representation that any use of PT-141 is safe for any person. We summarize what studies measured and what the FDA label states, including the documented warnings — transient blood-pressure increases, the contraindication in uncontrolled hypertension, common nausea — and we flag the open debates. Reading the record carefully is the only 'safe' we offer.
How we work
Every quantitative claim on this site — every dose, percentage, half-life, trial size, and effect size — maps to a numbered citation in our references list, drawn from sources including PubMed-indexed journals and the FDA prescribing information. Where the evidence is strong, we say so plainly; where it is contested or disputed, we mark it rather than smooth it over.
We avoid brand names and we do not sell, price, or source any product. The identifiers we publish — CAS 189691-06-3, UNII 6Y24O4F37N, DrugBank DB12420, INN bremelanotide, NDA 210557 — are public-record data points, presented as a datasheet would present them. If a reader wants the underlying source for any line, the PT-141 references page links it directly.